Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DEBRISOQUINE METABOLISM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Auer, H; Warncke, K; Nowak, D; Koops, F; Jaeger, U; Kurzbauer, R; Ruediger, HW
      Variations of p53 in cultured fibroblasts of patients with lung cancer whohave a presumed genetic predisposition

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    2. Tanaka, E
      Gender-related differences in pharmacokinetics and their clinical significance

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    3. Tanaka, E
      Clinically significant pharmacokinetic drug interactions between antiepileptic drugs

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    4. TANAKA E
      CLINICAL IMPORTANCE OF NONGENETIC AND GENETIC CYTOCHROME-P450 FUNCTION-TESTS IN LIVER-DISEASE

      Journal of clinical pharmacy and therapeutics
    5. Tanaka, E
      Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    6. DEGROOT MJ; BIJLOO GJ; VANACKER FAA; GUERRA CF; SNIJDERS JG; VERMEULEN NPE
      EXTENSION OF A PREDICTIVE SUBSTRATE MODEL FOR HUMAN CYTOCHROME P4502D6

      Xenobiotica
    7. MODI S; GILHAM DE; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR; ROBERTS GCK
      1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AS A SUBSTRATE OF CYTOCHROME-P450 2D6 - ALLOSTERIC EFFECTS OF NADPH-CYTOCHROME P450 REDUCTASE

      Biochemistry
    8. SANWALD P; DAVID M; DOW J
      USE OF ELECTROSPRAY-IONIZATION LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY TO STUDY THE ROLE OF CYP2D6 IN THE IN-VITRO METABOLISM OF 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONISTS

      Journal of chromatography B. Biomedical applications
    9. BORDET R; BROLY F; DESTEE A; LIBERSA C; LAFITTE JJ
      LACK OF RELATION BETWEEN GENETIC-POLYMORPHISM OF CYTOCHROME P-450IID6AND SPORADIC IDIOPATHIC PARKINSONS-DISEASE

      Clinical neuropharmacology
    10. LIN LY; FUJIMOTO M; DISTEFANO EW; SCHMITZ DA; JAYASINGHE A; CHO AK
      SELECTIVE MECHANISM-BASED INACTIVATION OF RAT CYP2D BY 4-ALLYLOXYMETHAMPHETAMINE

      The Journal of pharmacology and experimental therapeutics
    11. CAPON DA; BOCHNER F; KERRY N; MIKUS G; DANZ C; SOMOGYI AA
      THE INFLUENCE OF CYP2D6 POLYMORPHISM AND QUINIDINE ON THE DISPOSITIONAND ANTITUSSIVE EFFECT OF DEXTROMETHORPHAN IN HUMANS

      Clinical pharmacology and therapeutics
    12. BROCKMOLLER J; CASCORBI I; KERB R; ROOTS I
      COMBINED ANALYSIS OF INHERITED POLYMORPHISMS IN ARYLAMINE N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASES M1 AND T1, MICROSOMAL EPOXIDE HYDROLASE, AND CYTOCHROME-P450 ENZYMES AS MODULATORS OF BLADDER-CANCER RISK

      Cancer research
    13. MODI S; PAINE MJ; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR; ROBERTS GCK
      A MODEL FOR HUMAN CYTOCHROME-P-450 2D6 BASED ON HOMOLOGY MODELING ANDNMR-STUDIES OF SUBSTRATE-BINDING

      Biochemistry
    14. JACQZAIGRAIN E; PANSERAT S; SICA L; KRISHNAMOORTHY R
      MOLECULAR-GENETICS OF CYTOCHROME-P450-IID - ANOMALIES OF DRUG-METABOLISM

      Clinical reviews in allergy and immunology
    15. TREDANIEL J; ZALCMAN G; DOURIEZ E
      GENES AND ENZYMES INVOLVED IN CARCINOGEN METABOLISM

      Bulletin du cancer
    16. CAPORASO N; WHITEHOUSE J; MONKMAN S; BOUSTEAD C; ISSAQ H; FOX S; MORSE MA; IDLE JR; CHUNG FL
      IN-VITRO BUT NOT IN-VIVO INHIBITION OF CYP2D6 BY PHENETHYL ISOTHIOCYANATE (PEITC), A CONSTITUENT OF WATERCRESS

      Pharmacogenetics
    17. EVERT B; GRIESE EU; EICHELBAUM M
      A MISSENSE MUTATION IN EXON-6 OF THE CYP2D6 GENE LEADING TO A HISTIDINE-324 TO PROLINE EXCHANGE IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE OF SPARTEINE

      Naunyn-Schmiedeberg's archives of pharmacology
    18. KOYMANS LMH; VERMEULEN NPE; BAARSLAG A; DENKELDER GMDO
      A PRELIMINARY 3D MODEL FOR CYTOCHROME-P450 2D6 CONSTRUCTED BY HOMOLOGY MODEL-BUILDING

      Journal of computer-aided molecular design
    19. BRAKENHOFF JPG; COMMANDEUR JNM; LAMOREE MH; DUBELAAR AC; VANBAAR BLM; LUCAS C; VERMEULEN NPE
      IDENTIFICATION AND QUANTITATIVE-DETERMINATION OF GLUTATHIONE-RELATED URINARY METABOLITES OF FOTEMUSTINE, A NEW ANTICANCER AGENT

      Xenobiotica
    20. KOYMANS L; VERMEULEN NPE; VANACKER SABE; TEKOPPELE JM; HEYKANTS JJP; LAVRIJSEN K; MEULDERMANS W; DENKELDER GMD
      A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6)

      Chemical research in toxicology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 23:21:58